Skip to main content
. Author manuscript; available in PMC: 2015 Feb 24.
Published in final edited form as: Immunobiology. 2013 Aug 23;219(2):104–108. doi: 10.1016/j.imbio.2013.08.007

Fig. 1.

Fig. 1

The clinical course of active EAE is attenuated in CPN−/− mice compared to wild type mice. Active EAE was induced with MOG35-55 peptide and clinical signs scored for 30 days as described in Materials and Methods. CPN−/− mice (n=10) have significantly reduced disease from day 10 through 30 (p<0.001, Wilcoxon rank sum test) compared to wild type mice (n=13). Results shown are the daily mean clinical score for wild type and CPN−/− mice from four experiments.